About Pharmaceutics International
Pharmaceutics International is a private company based in Hunt Valley, Maryland. It has reported $206,479,419 raised in 17 offerings on Form D since September 2016.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 3, 2024 | Jun 11, 2024amended Oct 23, 2024 | $11,249,998fully sold | 3 | $3.7M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Mar 6, 2024 | Mar 13, 2024 | $4,249,989fully sold | 6 | $708K | EquityRule 506(b) | Form D ↗ |
| Jun 16, 2023 | Jun 27, 2023 | $6,000,000of $12.0M target | 2 | $3.0M | EquityRule 506(b) | Form D ↗ |
| Dec 8, 2022 | Dec 12, 2022 | $3,000,159fully sold | 5 | $600K | EquityRule 506(b) | Form D ↗ |
| Sep 23, 2022 | Oct 7, 2022 | $9,007,812fully sold | 5 | $1.8M | EquityRule 506(b) | Form D ↗ |
| Aug 8, 2022 | Aug 22, 2022 | $5,000,319fully sold | 5 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Jun 27, 2022 | Jul 12, 2022 | $5,000,319fully sold | 5 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Apr 27, 2022 | May 5, 2022 | $5,000,000fully sold | 4 | $1.2M | DebtRule 506(b) | Form D ↗ |
| Mar 2, 2022 | Mar 17, 2022 | $5,000,319fully sold | 4 | $1.2M | EquityRule 506(b) | Form D ↗ |
| Dec 21, 2021 | Jan 11, 2022 | $5,000,159fully sold | 2 | $2.5M | EquityRule 506(b) | Form D ↗ |
| Oct 14, 2021 | Oct 29, 2021 | $5,000,159fully sold | 2 | $2.5M | EquityRule 506(b) | Form D ↗ |
| Jul 23, 2021 | Aug 6, 2021 | $6,000,000fully sold | 5 | $1.2M | EquityRule 506(b) | Form D ↗ |
| Dec 31, 2020 | Jun 4, 2021 | $10,000,000fully sold | 6 | $1.6M | EquityRule 506(b) | Form D ↗ |
| May 21, 2021 | Jun 4, 2021 | $3,000,159fully sold | 4 | $750K | EquityRule 506(b) | Form D ↗ |
| Oct 22, 2018 | Oct 29, 2018 | $5,971,142of $15.0M target | 5 | $1.1M | EquityRule 506(b) | Form D ↗ |
| Aug 3, 2017 | Aug 15, 2017 | $9,999,522of $19.9M target | 6 | $1.6M | EquityRule 506(b) | Form D ↗ |
| Aug 31, 2016 | Sep 14, 2016 | $107,999,363fully sold | 9 | $11.9M | Equity, DebtRule 506(b) | Form D ↗ |
| Total, 17 offerings | $206,479,419 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Pharmaceutics International's Form D filed Oct 23, 2024.
Earlier filings also listed Joseph Kiely (chief financial officer, last listed Mar 2024), Sana Abidi (director, last listed Oct 2022), John Guthrie (chief financial officer, last listed Oct 2022), Shahab Abidi (director, last listed Aug 2022), Syed Abidi (director, last listed Jul 2022), Kurt Nielsen, Ph.D. (executive officer and director, last listed Jan 2022), George Svokos (director, last listed Oct 2021) and Kevin Walsh (director, last listed Oct 2018).